| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,518 |
10,962 |
$798K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,440 |
10,757 |
$760K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,118 |
8,322 |
$581K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,555 |
3,014 |
$526K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,343 |
5,845 |
$378K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,701 |
2,351 |
$148K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,498 |
1,775 |
$147K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,307 |
1,985 |
$143K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,027 |
2,485 |
$131K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,304 |
2,162 |
$129K |
| 80053 |
Comprehensive metabolic panel |
10,718 |
8,159 |
$122K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,960 |
1,834 |
$113K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,552 |
1,294 |
$101K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,919 |
1,740 |
$95K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,317 |
1,960 |
$93K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,282 |
1,095 |
$82K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,039 |
957 |
$81K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,919 |
1,756 |
$80K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,687 |
10,215 |
$80K |
| 99215 |
Prolong outpt/office vis |
1,303 |
1,180 |
$76K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,832 |
1,615 |
$70K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,409 |
865 |
$64K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,166 |
1,106 |
$63K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
984 |
897 |
$62K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,104 |
2,782 |
$59K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,006 |
889 |
$55K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
791 |
648 |
$53K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,627 |
2,275 |
$48K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,612 |
3,625 |
$47K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
572 |
499 |
$46K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,021 |
830 |
$42K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
838 |
741 |
$40K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
7,333 |
5,830 |
$40K |
| 90670 |
|
978 |
893 |
$36K |
| 84484 |
|
3,515 |
2,309 |
$33K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
497 |
414 |
$29K |
| 80061 |
Lipid panel |
2,027 |
1,773 |
$29K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
333 |
205 |
$28K |
| 81001 |
|
7,425 |
6,125 |
$27K |
| 90674 |
|
1,741 |
1,565 |
$27K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
938 |
759 |
$26K |
| 87634 |
|
572 |
499 |
$26K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,425 |
2,044 |
$25K |
| 83735 |
|
5,410 |
4,096 |
$23K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
603 |
539 |
$23K |
| 81025 |
|
2,307 |
1,933 |
$23K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,270 |
2,007 |
$22K |
| 99243 |
|
341 |
313 |
$21K |
| 82728 |
|
1,360 |
1,201 |
$20K |
| 83880 |
|
708 |
594 |
$20K |
| 84145 |
|
844 |
711 |
$19K |
| 90680 |
|
932 |
840 |
$18K |
| 85610 |
|
2,464 |
1,827 |
$18K |
| 83690 |
|
3,507 |
2,690 |
$17K |
| 93296 |
|
610 |
565 |
$17K |
| 85027 |
|
2,301 |
1,920 |
$16K |
| 84702 |
|
493 |
343 |
$15K |
| 87186 |
|
835 |
680 |
$14K |
| 90633 |
|
566 |
522 |
$14K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
585 |
516 |
$14K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
843 |
571 |
$14K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
883 |
818 |
$13K |
| 83605 |
|
1,349 |
964 |
$13K |
| 82962 |
|
2,845 |
1,093 |
$12K |
| 86140 |
|
3,055 |
2,574 |
$12K |
| 80306 |
|
658 |
542 |
$12K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
212 |
193 |
$11K |
| 11721 |
|
251 |
236 |
$10K |
| 90715 |
|
825 |
739 |
$9K |
| 90651 |
|
265 |
249 |
$9K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
133 |
116 |
$9K |
| 80050 |
General health panel |
1,937 |
1,610 |
$8K |
| 86803 |
|
596 |
501 |
$8K |
| 59025 |
Fetal non-stress test |
114 |
69 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,409 |
4,952 |
$8K |
| 0001A |
|
569 |
527 |
$8K |
| 0002A |
|
498 |
469 |
$7K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
52 |
50 |
$7K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,222 |
4,497 |
$7K |
| 88142 |
|
425 |
304 |
$7K |
| 81514 |
|
50 |
39 |
$6K |
| 90619 |
|
179 |
164 |
$6K |
| 82077 |
|
699 |
549 |
$6K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
81 |
77 |
$6K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
94 |
82 |
$6K |
| 93298 |
|
172 |
163 |
$6K |
| 87081 |
|
260 |
223 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
960 |
819 |
$5K |
| 85379 |
|
716 |
612 |
$5K |
| 96367 |
|
86 |
67 |
$5K |
| 74018 |
|
646 |
564 |
$5K |
| 93976 |
|
180 |
164 |
$5K |
| 84439 |
|
671 |
586 |
$5K |
| 85730 |
|
1,153 |
887 |
$5K |
| 86850 |
|
1,293 |
1,054 |
$5K |
| 90686 |
|
550 |
523 |
$5K |
| 83550 |
|
722 |
650 |
$5K |
| 86780 |
|
447 |
371 |
$4K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
109 |
80 |
$4K |
| 87340 |
|
549 |
462 |
$4K |
| 90698 |
|
496 |
481 |
$4K |
| 81513 |
|
56 |
47 |
$4K |
| 97597 |
|
53 |
42 |
$4K |
| 73630 |
|
1,101 |
756 |
$4K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
97 |
86 |
$4K |
| 87653 |
|
75 |
69 |
$4K |
| 86703 |
|
306 |
253 |
$3K |
| 84703 |
|
439 |
377 |
$3K |
| 93297 |
|
169 |
159 |
$3K |
| 85652 |
|
1,663 |
1,424 |
$3K |
| 83540 |
|
684 |
612 |
$3K |
| 82784 |
|
330 |
302 |
$3K |
| 83655 |
|
158 |
144 |
$3K |
| 82950 |
|
231 |
200 |
$3K |
| 86762 |
|
143 |
119 |
$3K |
| 85018 |
|
648 |
523 |
$3K |
| 86900 |
|
1,216 |
991 |
$3K |
| 87040 |
|
385 |
190 |
$2K |
| 96376 |
|
2,116 |
1,330 |
$2K |
| 90716 |
|
75 |
69 |
$2K |
| 73562 |
|
481 |
386 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
982 |
846 |
$2K |
| G0378 |
Hospital observation service, per hour |
848 |
594 |
$2K |
| 86901 |
|
1,215 |
990 |
$2K |
| 0012A |
|
119 |
110 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
82 |
65 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
41 |
36 |
$2K |
| 82570 |
|
492 |
410 |
$2K |
| 76801 |
|
47 |
39 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
97 |
77 |
$2K |
| 72100 |
|
192 |
167 |
$2K |
| 87077 |
|
259 |
213 |
$2K |
| 87070 |
|
150 |
126 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
41 |
38 |
$2K |
| 86364 |
|
192 |
175 |
$2K |
| 90661 |
|
228 |
223 |
$2K |
| 96415 |
|
18 |
12 |
$2K |
| 82607 |
|
126 |
111 |
$2K |
| 90696 |
|
88 |
73 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
84 |
78 |
$1K |
| 94060 |
|
46 |
37 |
$1K |
| 87481 |
|
56 |
47 |
$1K |
| 0011A |
|
129 |
111 |
$1K |
| 90734 |
|
50 |
46 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
28 |
28 |
$1K |
| 99205 |
Prolong outpt/office vis |
15 |
15 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
753 |
669 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,420 |
3,797 |
$1K |
| 71045 |
Radiologic examination, chest; single view |
3,109 |
2,587 |
$1K |
| 84450 |
|
332 |
286 |
$1K |
| 99245 |
|
30 |
28 |
$1K |
| 83970 |
|
52 |
44 |
$1K |
| 0240U |
|
47 |
40 |
$1K |
| 80051 |
|
233 |
181 |
$1K |
| 82947 |
|
295 |
235 |
$1K |
| 0004A |
|
26 |
21 |
$968.23 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
73 |
63 |
$929.58 |
| 84460 |
|
224 |
193 |
$926.50 |
| 36415 |
Collection of venous blood by venipuncture |
19,487 |
14,445 |
$919.04 |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
14 |
12 |
$910.90 |
| 20610 |
|
12 |
12 |
$895.30 |
| 76830 |
Ultrasound, transvaginal |
40 |
36 |
$884.45 |
| 86618 |
|
45 |
39 |
$865.58 |
| 90677 |
|
336 |
301 |
$850.58 |
| 82565 |
|
263 |
236 |
$830.64 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
35 |
25 |
$774.50 |
| 81003 |
|
214 |
184 |
$769.85 |
| 73610 |
|
397 |
306 |
$750.73 |
| 90697 |
|
538 |
475 |
$709.22 |
| 87075 |
|
35 |
26 |
$694.01 |
| 90744 |
|
123 |
122 |
$691.67 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
16 |
13 |
$636.60 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
779 |
578 |
$621.75 |
| 82043 |
|
170 |
153 |
$619.55 |
| 84520 |
|
233 |
181 |
$580.10 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
141 |
87 |
$577.46 |
| 88720 |
|
19 |
13 |
$546.82 |
| 82040 |
|
170 |
147 |
$542.70 |
| 84075 |
|
142 |
121 |
$492.68 |
| 70355 |
|
63 |
51 |
$483.32 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
46 |
39 |
$460.78 |
| 36591 |
|
417 |
217 |
$455.79 |
| 90656 |
|
66 |
66 |
$440.39 |
| 87205 |
|
149 |
125 |
$404.90 |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
12 |
12 |
$364.24 |
| 90710 |
|
95 |
80 |
$333.98 |
| 84156 |
|
148 |
113 |
$325.61 |
| 0031A |
|
14 |
14 |
$311.98 |
| 90480 |
|
12 |
12 |
$270.55 |
| 90707 |
|
73 |
67 |
$246.98 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
16 |
12 |
$199.04 |
| 83001 |
|
13 |
12 |
$192.00 |
| 74019 |
|
121 |
111 |
$188.30 |
| 80069 |
|
49 |
43 |
$162.27 |
| 86038 |
|
16 |
13 |
$138.51 |
| 36592 |
|
4,291 |
3,433 |
$108.02 |
| 73502 |
|
12 |
12 |
$102.96 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
188 |
119 |
$77.34 |
| 76937 |
|
18 |
14 |
$71.18 |
| 82550 |
|
18 |
15 |
$60.57 |
| 85007 |
|
18 |
14 |
$44.28 |
| 87210 |
|
15 |
12 |
$42.00 |
| 73030 |
|
67 |
57 |
$37.22 |
| 0124A |
|
31 |
27 |
$37.17 |
| 51798 |
|
59 |
49 |
$35.78 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
37 |
12 |
$31.17 |
| 87088 |
|
15 |
13 |
$25.08 |
| 94664 |
|
13 |
12 |
$18.23 |
| 0072A |
|
40 |
40 |
$12.39 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
27 |
27 |
$6.19 |
| J2704 |
Injection, propofol, 10 mg |
1,703 |
1,439 |
$4.34 |
| J3490 |
Unclassified drugs |
2,275 |
1,485 |
$2.48 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
2,927 |
2,142 |
$1.03 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,450 |
3,458 |
$0.82 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,984 |
1,644 |
$0.69 |
| J1815 |
Injection, insulin, per 5 units |
18 |
12 |
$0.23 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,463 |
3,321 |
$0.14 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,222 |
2,466 |
$0.07 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
229 |
197 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
39 |
31 |
$0.00 |
| 73130 |
|
33 |
24 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
327 |
243 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,197 |
922 |
$0.00 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
26 |
14 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
313 |
220 |
$0.00 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
738 |
378 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
226 |
163 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,781 |
1,301 |
$0.00 |
| 73110 |
|
16 |
12 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
197 |
176 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
177 |
137 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
19 |
12 |
$0.00 |
| 99152 |
|
21 |
16 |
$0.00 |
| 0071A |
|
13 |
12 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
27 |
26 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
16 |
14 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
50 |
39 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
18 |
12 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
21 |
13 |
$0.00 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
85 |
77 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,713 |
1,440 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,750 |
1,498 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
64 |
51 |
$0.00 |
| C1769 |
Guide wire |
307 |
253 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
347 |
206 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,194 |
1,806 |
$0.00 |
| 3044F |
|
49 |
48 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
937 |
683 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,534 |
1,867 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
277 |
194 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
52 |
42 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
275 |
221 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,850 |
1,920 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
161 |
131 |
$0.00 |
| A9270 |
Non-covered item or service |
1,212 |
836 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
144 |
132 |
$0.00 |
| J3535 |
Drug administered through a metered dose inhaler |
95 |
80 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
16 |
15 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
18 |
12 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
34 |
31 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
94 |
82 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
37 |
30 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
31 |
26 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
22 |
20 |
$0.00 |